Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
| Autor: | Torka, Pallawi, Groman, Adrienne, Wong, Jerry, Nichols, Jenna, Kader, Angela, Mavis, Cory, Anampa-Guzmán, Andrea, Sait, Sheila Jani, Block, AnneMarie, Przespolewski, Eugene, Mohr, Alice, Lund, Ian, McWhite, Kenneth, Kostrewa, Jessica, DeMarco, Joseph, Johnson, Michael, Darrall, Andrea, Thomas, Roshneke, Sundaram, Suchitra, Ghione, Paola, Hutson, Alan, Hernandez-Ilizaliturri, Francisco J. ∗ |
|---|---|
| Zdroj: | In Blood Advances 11 April 2023 7(7):1146-1155 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|